Ticker Launch

SPAC · Merger completed

Chardan Healthcare Acquisition Corp.

Business combination with BiomX Ltd.

Chardan Healthcare Acquisition Corp. is a blank-check company (SPAC) that raised $70M in its initial public offering on Dec 14, 2018. It completed its business combination with BiomX Ltd. on Oct 28, 2019; the combined company is BiomX Inc. (PHGE). Loeb & Loeb advised the SPAC and Schiff Hardin advised the underwriters on the IPO.

BiomX Ltd. is a preclinical-stage microbiome company developing natural and engineered phage cocktails to destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases such as IBD, PSC and cancer.

Status
Merger completed
IPO date
Dec 14, 2018
IPO size
$70M
Target
BiomX Ltd.
Announced
Jul 17, 2019
Closed
Oct 28, 2019
Combined company
BiomX Inc. (PHGE)
SPAC counsel (IPO)
Loeb & Loeb
Underwriters' counsel (IPO)
Schiff Hardin

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2019